LL-37 5mg (CAP-18)

$95.00

LL-37 5mg is the synthetic 37-amino-acid C-terminal fragment of the human cathelicidin antimicrobial peptide hCAP-18, the only cathelicidin expressed in humans. Cationic amphipathic alpha-helical peptide with direct membrane-disruption and immunomodulatory activity. Greater than 99 percent HPLC verified.

Category:

Peptide Science research editorial team.

LL-37 5mg (CAP-18) Overview

LL-37 5mg from Peptide Science is the synthetic 37-amino-acid C-terminal fragment of the human cathelicidin antimicrobial peptide hCAP-18, supplied as a lyophilised vial for in-vitro innate-immunity and antimicrobial research. LL-37 is the only cathelicidin peptide expressed in humans and is one of the most-cited antimicrobial peptides in published immunology literature.

Compound Class and Mechanism

LL-37 is cleaved proteolytically from the parent 18-kilodalton hCAP-18 (human Cathelicidin Antimicrobial Protein 18) following secretion from neutrophil granules and other immune cell types. The 37-residue cationic amphipathic alpha-helical peptide has been characterised in preclinical research for direct membrane-disruption antimicrobial activity against gram-positive and gram-negative bacteria, as well as additional immunomodulatory effects on cytokine release and dendritic-cell signalling. Browse the broader immune-support peptide range.

Specifications

LL-37 5mg (CAP-18) research specifications
Property Value
Compound LL-37 (cathelicidin antimicrobial peptide hCAP-18 C-terminal fragment)
Class Cathelicidin-family antimicrobial peptide; innate-immunity research compound
Amino-acid count 37
Molecular weight approximately 4493 g/mol
Supplied form Lyophilised powder, sealed vial
Strength 5 mg per vial
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For paired research with the other characterised immune-modulating peptide, see Thymosin Alpha-1 10mg or KPV Peptide 5mg.

Reconstitution and Handling

The lyophilised vial reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard preclinical handling practice cited in peptide-research literature.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws.

Reviews

There are no reviews yet.

Be the first to review “LL-37 5mg (CAP-18)”

Your email address will not be published. Required fields are marked *

Scroll to Top